Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003666-17Phase 4Terminated
Phase 4 trial of aspirin and tranexamic acid in coronary arteriosclerosis, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: All-cause 30-day mortality. Started Sep 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003666-17.